Daliresp

Piper Jaffray released a research report on Forest Laboratories (NASDAQ: FRX) announcing there is mixed feedback on Daliresp from a physician expert. In the report, Piper Jaffray writes, “We hosted a call with Dr. James Donohue, a thought leader in chronic obstructive pulmonary disease (COPD) and...

CIGNA (NYSE: CI) and Forest Laboratories (NYSE: FRX) reached new 52-week highs of $50.70 and $37.87 per share, respectively, on Thursday but were lower in premarket trading Friday. CIGNA was raised to Outperform as yesterday's Bull of the Day at Zacks. The company has a market cap of $13.6...